| ATHS |
|
atherosclerosis susceptibility (lipoprotein associated)
|
|
|
0.551 |
0.769 |
| BCYRN1 |
|
brain cytoplasmic RNA 1
|
|
|
0.666 |
0.423 |
| BTF3P11 |
|
basic transcription factor 3 pseudogene 11
|
|
|
0.519 |
0.731 |
| CTAA1 |
|
cataract, anterior polar 1
|
|
|
0.568 |
0.731 |
| EEF1B2P2 |
|
eukaryotic translation elongation factor 1 beta 2 pseudogene 2
|
|
|
0.612 |
0.577 |
| HOXA@ |
|
homeobox A cluster
|
|
|
0.599 |
0.654 |
| HTC2 |
|
hypertrichosis 2 (generalized, congenital)
|
|
|
0.392 |
0.808 |
| MAA |
|
microphthalmia or anophthalmia and associated anomalies
|
|
|
0.666 |
0.577 |
| MT1JP |
|
metallothionein 1J, pseudogene
|
|
|
0.588 |
0.731 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| PKD3 |
|
polycystic kidney disease 3 (autosomal dominant)
|
|
|
0.760 |
0.308 |
| PVT1 |
|
Pvt1 oncogene
|
|
|
0.495 |
0.731 |
| RMRP |
|
RNA component of mitochondrial RNA processing endoribonuclease
|
|
|
0.519 |
0.731 |
| SAI1 |
|
suppression of anchorage independence 1
|
|
|
0.560 |
0.615 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| TERC |
|
telomerase RNA component
|
|
|
0.471 |
0.846 |
| XIST |
|
X inactive specific transcript
|
|
|
0.522 |
0.808 |
| LEPQTL1 |
|
Leptin, serum levels of
|
|
|
0.638 |
0.385 |
| SCLC1 |
|
small cell cancer of the lung
|
|
|
0.612 |
0.577 |
| AD5 |
|
Alzheimer disease 5
|
|
|
0.769 |
0.231 |
| MLRL |
|
Myeloid leukemia-related gene (myeloid tumor suppressor)
|
|
|
0.564 |
0.769 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| SNHG3 |
|
small nucleolar RNA host gene 3
|
|
|
0.682 |
0.385 |
| MMP23A |
|
matrix metallopeptidase 23A (pseudogene)
|
|
|
0.722 |
0.308 |
| DLEU2 |
|
deleted in lymphocytic leukemia 2
|
|
|
0.650 |
0.500 |